Vistagen Therapeutics Inc (VTGN)
4.50
+0.09
(+2.04%)
USD |
NASDAQ |
May 03, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 20:00
Vistagen Therapeutics Max Drawdown (5Y): 98.38% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 98.38% |
| March 31, 2024 | 98.38% |
| February 29, 2024 | 98.38% |
| January 31, 2024 | 98.38% |
| December 31, 2023 | 98.38% |
| November 30, 2023 | 98.38% |
| October 31, 2023 | 98.38% |
| September 30, 2023 | 98.38% |
| August 31, 2023 | 98.38% |
| July 31, 2023 | 98.38% |
| June 30, 2023 | 98.37% |
| May 31, 2023 | 98.21% |
| April 30, 2023 | 98.21% |
| March 31, 2023 | 98.21% |
| February 28, 2023 | 98.21% |
| January 31, 2023 | 98.21% |
| December 31, 2022 | 98.21% |
| November 30, 2022 | 98.21% |
| October 31, 2022 | 98.21% |
| September 30, 2022 | 98.21% |
| August 31, 2022 | 98.21% |
| July 31, 2022 | 98.21% |
| June 30, 2022 | 98.21% |
| May 31, 2022 | 98.21% |
| April 30, 2022 | 98.21% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.21% |
| February 28, 2022 | 98.21% |
| January 31, 2022 | 98.21% |
| December 31, 2021 | 98.21% |
| November 30, 2021 | 98.21% |
| October 31, 2021 | 98.21% |
| September 30, 2021 | 98.21% |
| August 31, 2021 | 98.21% |
| July 31, 2021 | 98.21% |
| June 30, 2021 | 98.21% |
| May 31, 2021 | 98.21% |
| April 30, 2021 | 98.21% |
| March 31, 2021 | 98.21% |
| February 28, 2021 | 98.21% |
| January 31, 2021 | 98.21% |
| December 31, 2020 | 98.21% |
| November 30, 2020 | 98.21% |
| October 31, 2020 | 98.21% |
| September 30, 2020 | 98.21% |
| August 31, 2020 | 98.21% |
| July 31, 2020 | 98.21% |
| June 30, 2020 | 98.21% |
| May 31, 2020 | 98.21% |
| April 30, 2020 | 98.21% |
| March 31, 2020 | 98.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.76%
Minimum
May 2019
98.38%
Maximum
Jul 2023
98.12%
Average
98.21%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Ardelyx Inc | 95.33% |
| Axsome Therapeutics Inc | 81.26% |
| Vir Biotechnology Inc | -- |
| Immuneering Corp | -- |
| NovaBay Pharmaceuticals Inc | 99.91% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.96 |
| Beta (5Y) | 0.8418 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 182.7% |
| Historical Sharpe Ratio (5Y) | -0.1838 |
| Historical Sortino (5Y) | -0.5288 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 49.09% |